Procter & Gamble Health Limited (PGHL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Procter & Gamble Health Limited (PGHL) has a cash flow conversion efficiency ratio of 0.278x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs1.72 Billion ≈ $18.63 Million USD) by net assets (Rs6.20 Billion ≈ $67.02 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Procter & Gamble Health Limited (PGHL) market capitalisation for the company's overall valuation and market capitalisation.
Procter & Gamble Health Limited - Cash Flow Conversion Efficiency Trend (2003–2024)
This chart illustrates how Procter & Gamble Health Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Procter & Gamble Health Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Procter & Gamble Health Limited ranked by their cash flow conversion efficiency. Explore PGHL operating cash flow to net income to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Nsfocus Information Technology Co Ltd
SHE:300369
|
-0.005x |
|
Shenzhen Minkave Technology Co Ltd
SHE:300506
|
0.013x |
|
National Presto Industries Inc
NYSE:NPK
|
0.079x |
|
TWO HARBORS INV. DL-0001
F:2H2
|
0.066x |
|
HyUnion Holding Co Ltd
SHE:002537
|
0.017x |
|
AMAG Austria Metall AG
VI:AMAG
|
0.035x |
|
BlackRock Technology and Private Equity Term Trust
NYSE:BTX
|
-0.007x |
|
Sinosteel Anhui Tianyuan Technology Co Ltd
SHE:002057
|
0.015x |
Annual Cash Flow Conversion Efficiency for Procter & Gamble Health Limited (2003–2024)
The table below shows the annual cash flow conversion efficiency of Procter & Gamble Health Limited from 2003 to 2024. View current stock price of Procter & Gamble Health Limited for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rs5.37 Billion ≈ $58.07 Million |
Rs1.76 Billion ≈ $19.02 Million |
0.327x | -22.79% |
| 2023-12-31 | Rs5.38 Billion ≈ $58.21 Million |
Rs2.28 Billion ≈ $24.69 Million |
0.424x | +34.94% |
| 2022-12-31 | Rs7.51 Billion ≈ $81.21 Million |
Rs2.36 Billion ≈ $25.52 Million |
0.314x | +14.30% |
| 2021-12-31 | Rs6.16 Billion ≈ $66.67 Million |
Rs1.70 Billion ≈ $18.33 Million |
0.275x | -21.74% |
| 2020-12-31 | Rs7.04 Billion ≈ $76.10 Million |
Rs2.47 Billion ≈ $26.74 Million |
0.351x | +7.61% |
| 2019-12-31 | Rs9.06 Billion ≈ $98.02 Million |
Rs2.96 Billion ≈ $32.00 Million |
0.327x | +485.69% |
| 2018-12-31 | Rs15.40 Billion ≈ $166.56 Million |
Rs-1.30 Billion ≈ $-14.10 Million |
-0.085x | -215.68% |
| 2017-12-31 | Rs7.33 Billion ≈ $79.30 Million |
Rs536.60 Million ≈ $5.80 Million |
0.073x | -55.87% |
| 2016-12-31 | Rs6.45 Billion ≈ $69.80 Million |
Rs1.07 Billion ≈ $11.58 Million |
0.166x | +17.26% |
| 2015-12-31 | Rs5.92 Billion ≈ $63.97 Million |
Rs836.60 Million ≈ $9.05 Million |
0.141x | +1483.68% |
| 2014-12-31 | Rs5.54 Billion ≈ $59.95 Million |
Rs49.50 Million ≈ $535.32K |
0.009x | +937.95% |
| 2013-12-31 | Rs5.23 Billion ≈ $56.56 Million |
Rs4.50 Million ≈ $48.67K |
0.001x | -99.23% |
| 2012-12-31 | Rs4.84 Billion ≈ $52.31 Million |
Rs542.60 Million ≈ $5.87 Million |
0.112x | +280.13% |
| 2011-12-31 | Rs4.10 Billion ≈ $44.35 Million |
Rs-255.40 Million ≈ $-2.76 Million |
-0.062x | -132.70% |
| 2010-12-31 | Rs3.46 Billion ≈ $37.46 Million |
Rs659.70 Million ≈ $7.13 Million |
0.190x | +113.20% |
| 2009-12-31 | Rs4.67 Billion ≈ $50.54 Million |
Rs417.40 Million ≈ $4.51 Million |
0.089x | +936.50% |
| 2008-12-31 | Rs4.51 Billion ≈ $48.82 Million |
Rs38.90 Million ≈ $420.69K |
0.009x | -90.44% |
| 2007-12-31 | Rs4.23 Billion ≈ $45.74 Million |
Rs381.10 Million ≈ $4.12 Million |
0.090x | -56.34% |
| 2006-12-31 | Rs3.93 Billion ≈ $42.50 Million |
Rs811.20 Million ≈ $8.77 Million |
0.206x | -20.21% |
| 2005-12-31 | Rs2.98 Billion ≈ $32.24 Million |
Rs771.20 Million ≈ $8.34 Million |
0.259x | -18.21% |
| 2004-12-31 | Rs2.48 Billion ≈ $26.84 Million |
Rs784.90 Million ≈ $8.49 Million |
0.316x | -14.07% |
| 2003-12-31 | Rs1.96 Billion ≈ $21.22 Million |
Rs722.30 Million ≈ $7.81 Million |
0.368x | -- |
About Procter & Gamble Health Limited
Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemical products in India and internationally. The company offers over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter … Read more